Cargando…
Tissue Microarray Analyses Suggest Axl as a Predictive Biomarker in HPV-Negative Head and Neck Cancer
SIMPLE SUMMARY: Despite many efforts, no predictive biomarkers that could guide clinical decision making and personalized treatment have been established for patients with head and neck squamous cell carcinoma. We propose that high expression of the tyrosine kinase receptor Axl identifies patients a...
Autores principales: | Busch, Chia-Jung, Hagel, Christian, Becker, Benjamin, Oetting, Agnes, Möckelmann, Nikolaus, Droste, Conrad, Möller-Koop, Christina, Witt, Melanie, Blaurock, Markus, Loges, Sonja, Rothkamm, Kai, Betz, Christian, Münscher, Adrian, Clauditz, Till S., Rieckmann, Thorsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997923/ https://www.ncbi.nlm.nih.gov/pubmed/35406601 http://dx.doi.org/10.3390/cancers14071829 |
Ejemplares similares
-
The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma
por: Borgmann, Mara, et al.
Publicado: (2022) -
Mass Spectrometric Comparison of HPV-Positive and HPV-Negative Oropharyngeal Cancer
por: Wurlitzer, Marcus, et al.
Publicado: (2020) -
Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016) -
Dual Inhibition of PARP and the Intra-S/G2 Cell Cycle Checkpoints Results in Highly Effective Radiosensitization of HPV-Positive HNSCC Cells
por: Hintelmann, Katharina, et al.
Publicado: (2021) -
DNA Damage Response during Replication Correlates with CIN70 Score and Determines Survival in HNSCC Patients
por: Bold, Ioan T., et al.
Publicado: (2021)